For citations:
Kudryashova A.M., Grebenkin D.Yu., Samsonov M.Yu., Filon O.V., Razzhivina V.A., Chernobrovkin M.G., Borisova O.V. DEVELOPMENT AND VALIDATION OF A METHOD FOR DETERMINING NEUTRALIZING ANTIBODIES TO PEMBROLIZUMAB IN HUMAN SERUM BASED ON INHIBITION OF BINDING OF PEMBROLIZUMAB TO ITS PD-1 TARGET BY ELISA. Medical Immunology (Russia). (In Russ.) https://doi.org/10.15789/1563-0625-DAV-3188
Email this article 